Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, May 21, 2024 | Back issues
Courthouse News Service Courthouse News Service

Tainted Syringes

A man claims in a class action filed this past week that the California Pharmacy and Compounding Center repackaged the drug Avastin – for off-label treatment of macular degeneration – into tainted syringes that deposited silicone in his eye.

SACRAMENTO, Calif. – A man claims in a class action filed this past week that the California Pharmacy and Compounding Center repackaged the drug Avastin – for off-label treatment of macular degeneration – into tainted syringes that deposited silicone in his eye.

Categories / Briefs, Courts

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...